AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-5.45%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.74B
AUM Growth
+$3.74B
(-13%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-4.47%
Top 10 Holdings %
Top 10 Hldgs %
31.26%
Holding
292
New
63
Increased
73
Reduced
62
Closed
70
Top Buys
| 1 |
Freshpet
FRPT
|
$59.6M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$54.6M |
| 3 |
Keurig Dr Pepper
KDP
|
$37.6M |
| 4 |
STAAR Surgical
STAA
|
$37.5M |
| 5 |
Smith & Nephew
SNN
|
$36.2M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$84.4M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$79.9M |
| 3 |
GSK
GSK
|
$77.5M |
| 4 |
AB InBev
BUD
|
$68M |
| 5 |
Humana
HUM
|
$67.7M |
Sector Composition
| 1 | Healthcare | 63.24% |
| 2 | Consumer Discretionary | 12.22% |
| 3 | Consumer Staples | 9.75% |
| 4 | Technology | 9.6% |
| 5 | Communication Services | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
GE HealthCare
GEHC
$33B
| $24.5M | 0.37% |
303,060
-91,251
| -23% | -$7.36M |
|
52
Workday
WDAY
$61.8B
| $24.3M | 0.36% |
103,886
-10,820
| -9% | -$2.53M |
|
|
53
Vertex Pharmaceuticals
VRTX
$101B
| $24.2M | 0.36% |
50,000
-174,016
| -78% | -$84.4M |
|
54
Datadog
DDOG
$45.9B
| $23.8M | 0.36% |
240,000
+48,213
| +25% | +$4.78M |
|
|
BCYC
55
Bicycle Therapeutics
BCYC
$493M
| $22.7M | 0.34% |
2,672,000
+476,000
| +22% | +$4.04M |
|
56
Disc Medicine
IRON
$2.15B
| $21.6M | 0.32% |
436,000
+80,000
| +22% | +$3.97M |
|
57
Nomad Foods
NOMD
$2.3B
| $20.1M | 0.3% |
1,025,064
-649,122
| -39% | -$12.8M |
|
58
Ironwood Pharmaceuticals
IRWD
$195M
| $20.1M | 0.3% |
13,700,000
+4,232,000
| +45% | +$6.22M |
|
59
Helen of Troy
HELE
$595M
| $19.8M | 0.3% |
+371,000
| New | +$19.8M |
|
60
Estee Lauder
EL
$32.5B
| $19.7M | 0.3% |
+299,157
| New | +$19.7M |
|
61
AngioDynamics
ANGO
$419M
| $19.7M | 0.29% |
2,094,000
+1,222,000
| +140% | +$11.5M |
|
62
Churchill Downs
CHDN
$7.08B
| $19.5M | 0.29% |
175,308
-283
| -0.2% | -$31.4K |
|
63
Trevi Therapeutics
TRVI
$887M
| $18.8M | 0.28% |
+2,988,000
| New | +$18.8M |
|
64
UiPath
PATH
$5.78B
| $18.5M | 0.28% |
1,799,689
+1,237,782
| +220% | +$12.7M |
|
65
Voyager Therapeutics
VYGR
$207M
| $18.4M | 0.28% |
5,436,000
+40,000
| +0.7% | +$135K |
|
66
Wyndham Hotels & Resorts
WH
$6.56B
| $18.1M | 0.27% |
199,983
-24,646
| -11% | -$2.23M |
|
67
SharkNinja
SN
$16.6B
| $17.5M | 0.26% |
210,359
+72,538
| +53% | +$6.05M |
|
68
Icon
ICLR
$14B
| $17.5M | 0.26% |
100,052
-318,060
| -76% | -$55.7M |
|
69
Uber
UBER
$193B
| $17.2M | 0.26% |
235,747
-99,788
| -30% | -$7.27M |
|
|
AUTL
70
Autolus Therapeutics
AUTL
$389M
| $17.1M | 0.26% |
11,000,000
+1,800,000
| +20% | +$2.79M |
|
71
RH
RH
$4.11B
| $17M | 0.25% |
72,566
+52,625
| +264% | +$12.3M |
|
72
Skechers
SKX
$9.49B
| $16.8M | 0.25% |
295,340
+2,707
| +0.9% | +$154K |
|
73
Danaher
DHR
$144B
| $16.6M | 0.25% |
+80,992
| New | +$16.6M |
|
|
74
Humana
HUM
$37.5B
| $14.8M | 0.22% |
56,023
-255,977
| -82% | -$67.7M |
|
75
Exxon Mobil
XOM
$478B
| $14.7M | 0.22% |
123,266
-69,190
| -36% | -$8.23M |
|